Skip to content

Company · founded 2008

Crinetics Pharmaceuticals (United States)

San Diego, United States · crinetics.com

Manage this page

Citations, last 5 years: 494
Works, last 5 years: 89
h-index: 40
Scientists listed: 14
Grants since 2016: 5

Grants received

2017–2020 · research · R44

Nonpeptide, oral somatostatin agonists for congenital hyperinsulinemias

Stephen F Betz · Crinetics Pharmaceuticals (United States) · funded by National Institutes of Health

$998.7k

2017–2018 · research · R44

Nonpeptide, oral somatostatin agonists for congenital hyperinsulinemias

Stephen F Betz · Crinetics Pharmaceuticals (United States) · funded by National Institutes of Health

$297.4kHyperglycemia and glycemic control in critically ill and hospitalized patients

2017–2020 · research · R44

Nonpeptide, oral somatostatin agonists for congenital hyperinsulinemias

Stephen F Betz · Crinetics Pharmaceuticals (United States) · funded by National Institutes of Health

$896.8k

2017–2018 · research · R43

Discovery of novel small molecule drugs for Cushing's disease

Richard Scott Struthers · Crinetics Pharmaceuticals (United States) · funded by National Institutes of Health

$299.5kPituitary Gland Disorders and Treatments

2011–2020 · research · R44

Biased Agonism In GPCR Drug Discovery: Application To Somatostatin Agonists

Richard Scott Struthers · Crinetics Pharmaceuticals (United States) · funded by National Institutes of Health

$1.4MReceptor Mechanisms and Signaling